Skip to main content

and
  1. Article

    GROWTH AND ENDOCRINE FUNCTION AFTER BONE MARROW TRANSPLANTATION (BMT) WITH OR WITHOUT TOTAL BODY IRRADIATION (TBI)

    TBI preparing to BMT is frequently followed by growth retardation. As GH deficiency (GHD) is a well known complication of cranial irradiation, the purpose of this study was to evaluate the risk of GHD after TB...

    M Fontoura, R Brauner, R Rappaport, A Fischer, E Quintana, Jm Zucker in Pediatric Research (1988)

  2. Article

    FRENCH COLLABORATIVE STUDY ON EFFECT OF 3 YEARS LHRH ANALOGJE (LHRHa) TREATMENT ON GROWTH AND BONE MATURATION IN CENTRAL PRECOCIOUS PUBERTY (CPP)

    The LHRHa have been shown to suppress the secretion of gonadotropins and sex steroids in children with CPP and therefore to improve their predicted final height. The present study was designed to evaluate the ...

    R Brauner, M Fontoura, P Rochiccioli, S Cabrol, C Wemeau, J M Limal in Pediatric Research (1988)

  3. No Access

    Chapter

    Growth Hormone Secretion and Growth in Central Nervous System Irradiated Children

    External cranial irradiation is currently used in various therapeutic protocols for malignant systemic and intracranial diseases. Some patients receive spinal irradiation in addition. These therapies have sign...

    R. Rappaport, M. Fontoura, R. Brauner in Basic and Clinical Aspects of Growth Hormone (1988)

  4. Article

    53 SUSTAINED GROWTH IN SPITE OF RADIATION INDUCED GHD OCCURS ONLY AFTER LOW HYPOTHALAMO-PITUITARY DOSE

    Normal growth, despite GHD, has been reported after cranial radiation (CR) for leukemia (ALL). In order to analyze the characteristicsof the patients with GH peak <5 ng/ml after AITT, 2 groups were investigate...

    R Brauner, R Rappaport, M Fontoura, G Leverger, J M Zucker in Pediatric Research (1988)

  5. No Access

    Chapter and Conference Paper

    Growth hormone secretory dysfunction after hypothalamic and pituitary irradiation

    External cranial radiation is a major therapeutic tool in the treatment of various malignant diseases in children. As growth retardation has become a significant complication of this therapy, there have been q...

    R. Rappaport, M. Fontoura, R. Brauner in Advances in Growth Hormone and Growth Fact… (1989)

  6. No Access

    Chapter

    Plasma Growth Hormone-Binding Protein and Liver Receptor in Thalassemic Patients

    Children with thalassemia major often present with growth failure, the mechanism of which is not clear. They are not GH deficient but their plasma insulin-like growth factor I (IGFI) activity is markedly reduced ...

    M. C. Postel-Vinay, M. Fontoura, M. De Montalembert in Endocrine Disorders in Thalassemia (1995)